Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-026346

Chief Medical Officer acquired 7,545 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Soergel David Chief Medical Officer 2025-05-15 Grant or award +7,545 7,545 D
Derivatives
Soergel David Chief Medical Officer 2025-05-15 Grant or award · Stock Option (Right to Buy) +12,839 12,839 D
Loading xslF345X05/wk-form4_1747434224.xml…